Literature DB >> 16203484

Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia.

N Vincent1, J Schoobridge, A Ask, S Allsop, R Ali.   

Abstract

Phase I of this study was designed to inform the development of a range of responses to hazardous and harmful amphetamine use. Research techniques from Rapid Assessment Methodology (RAM) were utilized to collect data. A survey of current amphetamine users included the Short Form 36 (SF36) Health Status Questionnaire, for which South Australian population norms were published in 1995. This facilitated comparisons of the health of this sample of amphetamine users with that of the general population. The sample were found to have significantly poorer health than the general population. The self-reported prevalence of mental health problems in the sample was consistent with previous Australian research on amphetamine use. Approximately one-third of the sample reported that they had experienced symptoms of anxiety, depression, mood swings and aggressive outbursts prior to their use of amphetamines. Two-thirds of the sample reported symptoms of anxiety and depression since starting to use amphetamines, almost half reported mood swings and aggressive outbursts, and over a third reported panic attacks and paranoia. One of the most important findings was a strong association between mental and physical health problems and the severity of dependence on amphetamines. The implications of these results for interventions with amphetamine users are discussed.

Entities:  

Year:  1998        PMID: 16203484     DOI: 10.1080/09595239800186991

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  6 in total

1.  Alcohol and drug use among patients presenting to an inner-city emergency department: a latent class analysis.

Authors:  Frederic C Blow; Maureen A Walton; Kristen L Barry; Regan L Murray; Rebecca M Cunningham; Lynn S Massey; Stephen T Chermack; Brenda M Booth
Journal:  Addict Behav       Date:  2010-12-29       Impact factor: 3.913

Review 2.  Methamphetamine psychosis: epidemiology and management.

Authors:  Suzette Glasner-Edwards; Larissa J Mooney
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

Review 3.  Pharmacotherapy of methamphetamine addiction: an update.

Authors:  Ahmed Elkashef; Frank Vocci; Glen Hanson; Jason White; Wendy Wickes; Jari Tiihonen
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

Review 4.  Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Authors:  Jørgen G Bramness; Øystein Hoel Gundersen; Joar Guterstam; Eline Borger Rognli; Maija Konstenius; Else-Marie Løberg; Sigrid Medhus; Lars Tanum; Johan Franck
Journal:  BMC Psychiatry       Date:  2012-12-05       Impact factor: 3.630

5.  Tryptophan for the sleeping disorder and mental symptom of new-type drug dependence: A randomized, double-blind, placebo-controlled trial.

Authors:  Dongming Wang; Wenzhen Li; Yang Xiao; Wulong He; Weiquan Wei; Longyu Yang; Jincong Yu; Fujian Song; Zengzhen Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

6.  The Effect of High-frequency Repetitive Transcranial Magnetic Stimulation on Reducing Depression and Anxiety in Methamphetamine Users.

Authors:  Nastaran Mansouriyeh; Majid Mahmoud-Aliloo; Reza Rostami
Journal:  Addict Health       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.